International Health & Clinical Research is categorized under Health Services in Raynham, MA and active since 2010.
International Health & Clinical Research was established in 2010, and today employs 1 to 4, earning $50.000 to $99.999 per year. This is a Health Services business, which does work in the B2C market, and is classified as a Health Services, under code number 621999 by the NAICS.
If you are seeking more information, feel free to contact Abdul Zahir at the company’s single location by writing to 675 Paramount Drive, Raynham, Massachusetts MA 02767 or by phoning (508) 880-0140. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | International Health & Clinical Research |
| Contact Person: | Abdul Zahir |
| Address: | 675 Paramount Drive, Raynham, Massachusetts 02767 |
| Phone Number: | (508) 880-0140 |
| Annual Revenue (USD): | $50.000 to $99.999 |
| Founded: | 2010 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Health Services |
| SIC Code: | 8099 |
| NAICS Code: | 621999 |
| Share This Business: |
International Health & Clinical Research was started in 2010 to provide professional Health Services under the SIC code 8099 and NAICS code 621999. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $50.000 to $99.999 per annum.
Feel free to contact Abdul Zahir for inquiries that concern International Health & Clinical Research by calling the company number (508) 880-0140, as your correspondence is most welcome. Additionally, the physical location of the single location of International Health & Clinical Research can be found at the coordinates as well as the street address 675 Paramount Drive in Raynham, Massachusetts 02767.
For its online presence, you may visit International Health & Clinical Research’s website at and engage with its social media outlets through on Twitter and on Facebook.